MINI FUTURE SHORT - ABBOTT LABORATORIES Stock

Certificat

DE000PF61W97

Market Closed - Deutsche Boerse AG 15:50:35 2024-05-28 EDT
4.76 EUR +4.16% Intraday chart for MINI FUTURE SHORT - ABBOTT LABORATORIES
Current month+7.69%
1 month+11.74%
Date Price Change
24-05-28 4.76 +4.16%
24-05-27 4.57 0.00%
24-05-24 4.57 +0.88%
24-05-23 4.53 +0.44%
24-05-22 4.51 -3.01%

Delayed Quote Deutsche Boerse AG

Last update May 28, 2024 at 03:50 pm

More quotes

Static data

Product typeWarrant Knock-Out con Stop Loss
Buy / SellPUT
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PF61W9
ISINDE000PF61W97
Date issued 2021-02-17
Strike 153.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.17
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.21
Lowest since issue 1.53

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
102 USD
Average target price
125.7 USD
Spread / Average Target
+23.29%
Consensus